TruthArchive.ai - Related Video Feed

Pharmaceutical giants like GSK, Sanofi, Novartis, and Baxter have been given the green light by the WHO to sell millions of vaccines, resulting in billions of euros in revenue. However, concerns have been raised about the WHO's handling of the pandemic. The organization is accused of easily declaring a pandemic by changing the definition, removing the criteria of a high number of cases and deaths. This change has allowed the pharmaceutical companies to profit from the situation. It is revealed that contracts for vaccines were signed between wealthy countries and the companies in 2005, with the condition that the WHO declares a pandemic. Furthermore, conflicts of interest are highlighted, as many experts advising the WHO also work for these pharmaceutical companies. The race for vaccine production is now underway.

We are preparing for a complex vaccination program in Canada to immunize as many people as possible. We have been working closely with the military and expect a favorable decision soon for the Pfizer vaccine and others. We are still waiting for key information on the manufacturing process. Health Canada has authorized the first COVID-19 vaccine through a rigorous review process, meeting strict standards. We used the interim order pathway to review information as it becomes available. Canadians should feel comfortable getting the vaccine when it's their turn. Trust and agreement are crucial for the effectiveness of any vaccine.

Pfizer did not disclose SV40 DNA in COVID vaccine to regulators, causing concern among Health Canada officials. The presence of SV40 DNA was confirmed by Pfizer but not shared with FDA, EMA, or HC initially. Despite claims that the DNA fragment is inactive and below regulatory limits, concerns remain about potential risks. Health Canada is working with international partners to address the issue for future vaccine strains. The focus seems to be on vaccine acceptance rather than addressing health risks associated with DNA contamination. Pfizer has not responded to requests for comment.

The speakers discuss a contract between Pfizer and Canada, highlighting that it shows the government knew the vaccine's safety and efficacy were unknown. They criticize Trudeau for distancing himself from the contract and accuse the government of lying and covering up the truth. The speakers also mention that the contract lacks accountability and mention the issue of serialization. They argue that forcing people to take the vaccine without complete clinical trials is criminal. They express their belief that the government is evil and express their mission to expose and hold them accountable. The speakers also discuss the gender issue, batch differences, and the risks and uncertainties mentioned in the contract. They conclude by mentioning the removal of anti-bribery and anti-corruption sections from the contract.

A year ago, the speaker requested data from Emma, including all clinical trials done by medical companies before they requested marketing authorization for the green certificate. Regarding Pfizer, the speaker notes the company submitted a clinical trial that started on January 14, 2020. The speaker questioned a Pfizer representative about how tests for the vaccine began so soon after the December 2019 emergence of COVID-19, but the representative declined to answer. The speaker also asked the CEO of Moderna how they submitted trials since 2017, years before the virus was discovered in the winter of 2019. The speaker states that the CEO of Moderna did not answer how this was possible. The speaker says these are legitimate questions that people are asking, but unfortunately, the companies are declining to answer.

Vaccines are unique as the government defends companies against consumer claims in the vaccine injury program. Before 1986, only 3 vaccines were given, but now there are 19, totaling 84 injections. The National Childhood Vaccine Injury Act allowed companies to sell harmful products without consequences. This led to changes in clinical trials and regulatory treatment of vaccines. Regulatory agencies see themselves as partners with manufacturers. Translation: Vaccines are defended by the government against consumer claims. The number of vaccines has increased, and the law allows companies to sell harmful products without consequences. This has impacted clinical trials and regulatory treatment of vaccines. Regulatory agencies see themselves as partners with manufacturers.

Trump gave Moderna's COO a billion-dollar check to develop a vaccine quickly, bypassing FDA regulations. Human trials began after testing on mice. Many doubted the speed and safety of the process, but the vaccine was developed in 6 months. Concerns were raised by vaccine experts about the rushed development.

The cross-examination reveals that the government panel responsible for creating the vaccine mandate for travel in Canada lacked expertise in medicine and infectious diseases. The director general of the panel, Jennifer Little, invoked cabinet confidence when asked about who ordered the mandates. The panel received no solid scientific recommendation from health and science experts to implement the mandate. Furthermore, an email exchange between Transport Canada and the Public Health Agency of Canada (PHAC) showed a lack of specific scientific rationale for the mandate. Little admitted that implementing the mandate when only 50% of eligible Canadians were vaccinated would have caused chaos, but they waited until 80% were vaccinated. This raises questions about the true motivations behind the mandate.

During the pandemic, the development of vaccines surprised many due to its speed. The government's Operation Warp Speed invested $11 billion to accelerate the process, taking the risk out of it for pharmaceutical companies. Within 11 months, large phase three trials were conducted for Pfizer and Moderna's mRNA vaccines. Comparatively, the development of the polio vaccine took several years. Despite the rapid development and effectiveness of the COVID-19 vaccines, there was a significant portion of the population, around 30%, who chose not to get vaccinated. This resistance was unexpected and only strengthened the anti-vaccine movement. The speaker expresses frustration at the missed opportunities to prevent hospitalizations and deaths, particularly among unvaccinated children.

Over 100 million Americans were required to get vaccinated due to job mandates. The government claimed vaccines were safe and effective, but data showed vaccinated people could still carry the virus. Despite promises of freedom, there have been 1 million adverse events reported from COVID-19 vaccines, with only 11 compensated cases. Big Pharma has immunity from liability for vaccine injuries.

We are generating real-time data on mRNA vaccines, which have been in development for years due to side effects. Pfizer and Moderna used the pandemic to accelerate their development. The collaboration with BioNTech on flu led to the quick rollout of the mRNA vaccine. Clinical trials skipped phases, causing uncertainty. Concerns arise about vaccine distribution and the need for booster shots. Politics play a role in decision-making.

The transcript presents a critical examination of Bill Gates, portraying him as transforming from a software magnate into a global health power broker whose wealth and influence have reshaped public health, vaccine development, and population policy. It argues that Gates’ philanthropic activities are not purely charitable but are deployed to extend control over health systems, global research agendas, and even the reproductive choices of people worldwide. Key claims and points are detailed across several strands: - Public image and power shift: Bill Gates is described as no longer a “public health expert” yet becoming a central figure in billions of lives, guiding medical actions and vaccine strategies. The program asserts that Gates’ reinvention through the Bill and Melinda Gates Foundation has been aided by a sophisticated public relations apparatus and by directing media coverage of global health issues. - Foundation scale and reach: The Gates Foundation is depicted as the world’s largest private foundation, with assets reported as tens of billions of dollars and a broad remit in global health, development, growth, and policy advocacy. Its influence extends to funding media outlets, think tanks, and reporting units across multiple outlets (BBC, NPR, Our World in Data, ABC, among others), creating what the program calls “tentacles” across global health. - Partnerships and funding of global health initiatives: Gates is credited with initiating and funding major global health vehicles, including: - Gavi, the Vaccine Alliance, with seed funding and ongoing commitments that have shaped vaccination markets. - The Global Fund to Fight AIDS, Tuberculosis, and Malaria, and other public-private partnerships that coordinate vaccine development and immunization programs. - Support for CEPI (Coalition for Epidemic Preparedness Innovations), the World Health Organization’s vaccine initiatives, and other pandemic preparedness efforts. - The World Health Organization’s funding profile, described as heavily dependent on Gates Foundation support, with Tedros Adhanom Ghebreyesus noted as a non-medical doctor connected to Gates-backed initiatives. - The “Decade of Vaccines” and vaccine policy: Gates is credited with launching a decade-long vaccine initiative, including a pledge of billions of dollars to vaccine development and distribution. This is linked to the creation of a global vaccine action plan and to Gavi’s role in establishing vaccine markets. The narrative asserts that vaccines have been used to steer global health policy and to secure roles for private firms in public health decision-making. - Vaccine development concerns: The program raises concerns about the safety and speed of vaccine development, criticizing the eighteen-month timeline Gates advocates for a universal vaccine, and questioning the use of new technologies (DNA and mRNA platforms) and rapid deployment with limited testing. It highlights potential safety risks, including historical vaccine-associated disease enhancement and concerns about broad immunization in a short period. - Vaccine safety and regulation: It is claimed that vaccine safety at scale is hard to guarantee and that liability protections for vaccine makers and public health officials have been enacted (e.g., a U.S. declaration granting liability immunity for COVID-19 countermeasures), a point framed as enabling risk-bearing without accountability. - Population control framing: A central thread is the assertion that Gates seeks to reduce population growth through health improvements, vaccines, and reproductive health services. The transcript traces Gates’ interest in contraception and population issues to his family background and to Rockefeller-era eugenics historical contexts, arguing that discussions about fertility, contraceptive technologies, and demographic trends have long-term population implications. It cites specific Gates Foundation activities in reproductive health, including funding for innovative birth-control delivery methods, depot injections, implanted devices, and efforts to develop digital identity tied to health services as tools within a broader population-control framework. - Digital identity and biometric ID: The narrative emphasizes Gates’ involvement with biometric identification through Gavi and ID2020, noting partnerships with Microsoft and the Rockefeller Foundation, the Aadhaar system in India, and the World Bank’s ID4D initiative. It argues that vaccination programs, biometric identity, and cashless payments are being integrated into a comprehensive “population control grid,” enabling state and private actors to track, truncate, or deny access to services based on identity and health status. - Data, surveillance, and privacy concerns: The piece contends that the push for digital IDs, digital health records, and biometrics will erode privacy and enable broad government and corporate surveillance, linking health data to financial services, voting, housing, and welfare. It highlights projects involving digital certificates, immunity passports, and real-time health data collection via microneedle patches and barcode-like skin markers, suggesting these innovations could be used to control access to services. - Epstein connections and broader conspiracy context: The program references alleged connections between Gates and Jeffrey Epstein, including flight logs and involvement in philanthropic funding discussions, framing these ties as part of a broader pattern of influence. It also points to prior associations with notable figures (Buffett, Rockefeller, Soros) and critiques of Gates as aligning with a “population control” ideology. - The underlying motive and conclusion: Throughout, the narrative asserts that Gates’ wealth is being used not for charity alone but to build an overarching system of control—over health institutions, research funding, public policy, identification, and financial systems. It contrasts his public image as a generous philanthropist with alleged hidden agendas, suggesting that the real aim is to shape global governance and human behavior through vaccination, identification, and digital infrastructure. - Final framing and call to action: The closing sections urge viewers to recognize Gates’ influence as part of an ideology rather than a single person’s plan. It frames the situation as a broader movement that could continue beyond Gates personally, urging awareness and action to resist what the program deems a population-control regime embedded in global health and digital identity initiatives. In sum, the transcript portrays Bill Gates as a central figure driving a multifaceted, globally interconnected program—through the Gates Foundation, Gavi, CEPI, and related partnerships—that allegedly reconfigures vaccine policy, global health governance, reproductive health, biometric identification, and digital payments into a cohesive system of population control and surveillance, using philanthropy as a veneer for power and control.

Speaker 0 and Speaker 1 discuss the COVID-19 vaccine episode, challenging why the vaccine was pursued as a public health solution and exploring deeper incentives behind the program. - A knowledgeable figure at the stand answered a burning question: did they know the vaccine wouldn’t be effective from the start and could be dangerous? The answer given was that it was “a test of a technology.” The exchange suggests the broader aim was testing an entire program of control previewed in Event 2019. - They ask whether inoculation was necessary on billions, noting it could have been tested on a much smaller population. If shots had been basically empty or inert, the data could have been spun to claim success and end the pandemic, preventing injuries from appearing. The absence of that approach remains a mystery. - The speakers point to high pre-vaccine seroprevalence in 2020, including studies from South Dakota showing 50-60% seroprevalence before vaccine release, implying that a saline shot or no shot could have achieved “indomicity” (immunity) without a vaccine. - They discuss why people might fear vaccines and interpret the broader impact: the public is waking up to something terrible having occurred, as it revealed readiness to lie, potential data quality concerns, and risk to pregnant women and healthy children who might get little justification for risk. - The disease’s lethality is framed as greatest among the very old or very sick; for others, it was less deadly, with natural evolution potentially reducing vulnerability over time. - The mRNA platform was touted as a means to outrun mutations, but the timeline to release was still insufficient to stay ahead of natural change. They note accelerated development was the fastest vaccine in history, from detection to inoculation, reducing the timeline by about a year or two, yet not fast enough. - Political and logistical factors delayed release; there is mention that it would not have appeared under Trump and that Eric Topol argued to delay the rollout. Fauci reportedly sent Moderna back to trials due to insufficient racial diversity in participants. - The discussion questions whether the vaccine qualifies as a normal consumer product, given ongoing subsidies, mandates, indemnifications, wartime-like supports, and propaganda. They wonder if there has been an ongoing two-century revolt by industry against public scrutiny, with public interest repeatedly leading to pushback and rebranding. - A central theme is the sophistication of pharma: the “game of pharma” involves owning an IP-based health claim, crafting supportive research, convincing it is safe and effective, achieving standard-of-care status, securing mandates and government funding, and leveraging ongoing propaganda. They describe pharma as a long-running arms race with deep institutional knowledge, implying that it is far more capable of shaping reality than the public realizes.

The Pfizer COVID vaccine was not tested for its ability to stop the transmission of the virus before it entered the market. The speaker acknowledges that they had to work quickly to understand the situation and move at the speed of science.

The speaker cross-examined Dr. Lourenco about the safety of the COVID-19 vaccine. They compared it to previous vaccines like pneumonia and shingles, asking if the same rigorous testing process was followed. Dr. Lourenco confirmed that animal trials and two phases of human trials were conducted for those vaccines before approval. However, she admitted that the final phase of human trials, which has been completed for all other vaccines in Canada, was not done for the COVID-19 vaccines. She tried to justify this by mentioning a new process.

A Freedom of Information Act request to the CDC revealed that 80% of the additional 46 pages received were fully redacted. These redactions were made under the presidential communications privilege, indicating that the information shared was solicited or shared with the president or his senior advisers. The documents, dated May 2021, show that the White House, CDC, and NIH were concerned about thrombotic thrombocytopenia syndrome (TTS) and myocarditis. They held crisis meetings to formulate a media response, but subsequent statements from Dr. Fauci and Dr. Walensky downplayed the risks of myocarditis and blood clots. The documents suggest that they knew the truth but continued to promote the vaccines.

The speaker questions the secrecy surrounding COVID-19 vaccine contracts and the rush to develop them under Operation Warp Speed. They mention that these contracts are confidential and cannot be obtained through the Freedom of Information Act. The speaker also raises concerns about Pfizer's CEO allegedly trying to blackmail Argentina and Brazil. They wonder why such extreme measures are being taken and what information is being hidden. The speaker mentions that Bill Gates stated in 2020 that the final solution to the pandemic will be a... (transcript ends)

The speaker discovered a confidentiality agreement between the US and UK regarding vaccine adverse events. They express concern about why this information was being kept secret and mention a similar agreement with China during the early days of COVID. The speaker questions the need for secrecy and finds it troubling. This confidentiality agreement with the UK was previously unknown.

The pharmaceutical industry is seen as untrustworthy, being compared to a criminal cartel due to the large penalties they have paid for their other products. Vaccines, however, are exempt from liability, meaning companies cannot be sued no matter how negligent or reckless they are. This lack of accountability may lead to a lack of caution in product development.

Locking down entire populations and shutting down the economy were extreme measures taken to combat the pandemic. However, thanks to globalization, vaccines were developed in a record time of 9 months, compared to the usual 5 years. It is crucial to vaccinate globally to prevent the return of the virus in the form of new variants and increased contagion. Failure to do so will have negative consequences for us. Vaccination is not only important for recovery but also for anticipating future challenges.

We are preparing for a complex vaccination program in Canada. We expect a favorable decision soon for the approval of the Pfizer vaccine and others. However, we are still waiting for key information regarding the manufacturing process. Health Canada has authorized the first COVID-19 vaccine in Canada after a thorough assessment of the evidence. It was authorized under the Canadian Interim Order pathway, which allows for flexibility in the review process. Canadians can have confidence in our rigorous review process. If it is their turn to get the vaccine, they should feel comfortable getting it. We have always emphasized that even the best vaccine is only effective if people get vaccinated.

As of February 2024, the number of reports for COVID-19 vaccines in VAERS is significantly higher than all other vaccines combined since 1990. The government was not fully prepared for this overwhelming influx of reports. They had to quickly reassign people and hold numerous meetings to increase their capacity to review these reports.

Big companies said it wasn't possible, but Trump gave Moderna's COO $1 billion to develop a vaccine quickly. They started human trials after testing on mice. Many were skeptical, but the vaccine was ready in 6 months. Some experts raised concerns about the rushed development process.

Confidentiality agreements were required for Canadian government employees accessing these documents. The reason for extensive redactions is that these agreements were signed during the early stages of the pandemic when there was a rush to produce and test vaccines. Companies took on higher liability by fast-tracking the testing process, which normally takes years. Due to global competition for vaccines, countries had less negotiating power. The government prioritized signing as many vaccine contracts as possible to meet the urgent need for vaccinations. Ultimately, Canada successfully obtained vaccines and became one of the fastest countries to vaccinate its population.

Pfizer has been forced to release previously secret documents, including FDA approval packages, due to court orders and successful FOIA requests. These documents reveal that Pfizer tested different versions of their vaccine during preclinical and clinical trials, which goes against FDA guidance. The different versions included modified RNA, unmodified RNA, self-amplifying RNA, and Spike protein alone. Surprisingly, all these versions were tested under the same investigational new drug number, despite FDA guidance stating that multiple versions should have their own individual numbers. Additionally, the toxicity of the mRNA active ingredient in the COVID-19 vaccines was never studied. This raises concerns about the regulatory process and the lack of safety testing.